Accenture plc (ACN) delivered mixed results in Q3 FY2026 on revenue of $18.7B versus the $18.8B estimate (+5.6% YoY) and EPS of $3.80. The next Accenture plc (ACN) earnings date is Oct 1, 2026. Below is the full Accenture plc earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.
Accenture plc (ACN) Earnings Analysis — key stats
Next earnings date
Oct 1, 2026
Latest reported quarter
Q3 FY2026
Earnings verdict
Mixed
EPS beat rate
5 of last 8 (quarters above estimate)
Avg next-day move
±5.2% (over the last 8 reports)
Post-earnings direction
Up 3 / Down 4 (of the last 8 reports)
Implied move (next report)
±15.7% (options-derived · into Oct 1, 2026)
Institutional ownership
102.1% (13F as of 2026-06-30)
Top 10 holders
39.4% (of shares outstanding)
Insider activity
12 buys / 0 sells (recent Form 4 filings)
Revenue
$18.7B (vs $18.8B est · -0.3% surprise · +5.6% YoY)
EPS
$3.80 (vs $3.70 est · +2.7% surprise · +8.5% YoY)
Share price
$186.53 (+0.7%)
Market cap
$114.1B
Accenture plc (ACN) Earnings Analysis — beat / miss history
Quarter
Revenue
EPS
EPS surprise
Next-day move
Verdict
Q4 FY2026
$18.7B vs $18.8B est
$3.80 vs $3.70 est
+2.7%
-20.0%
Mixed
Q3 FY2026
$18.0B vs $17.8B est
$2.93 vs $2.86 est
+2.4%
+2.5%
Mixed
Q2 FY2026
$18.7B vs $18.5B est
$3.94 vs $3.74 est
+5.3%
-0.5%
Mixed
Q1 FY2026
$17.6B vs $17.4B est
$3.03 vs $2.98 est
+1.7%
+0.0%
In line
Q4 FY2025
$17.7B vs $17.3B est
$3.49 vs $3.35 est
+4.2%
-3.7%
Beat
Q3 FY2025
$16.7B vs $16.6B est
$2.82 vs $2.81 est
+0.4%
-5.9%
In line
Q2 FY2025
$17.7B vs $17.1B est
$3.59 vs $3.42 est
+5.0%
+5.4%
Beat
Q1 FY2025
$16.4B vs $16.4B est
$2.79 vs $2.78 est
+0.4%
+3.8%
In line
Top institutional holders
Holder
% outstanding
Shares
Value
QoQ change
Blackrock, INC.
10.2%
62.2M
$7.7B
+8.8%
Vanguard Capital Management LLC
6.5%
40.1M
$5.0B
+0.3%
State Street Corp
5.0%
30.8M
$3.8B
+6.8%
Charles Schwab Investment Management INC
3.5%
21.6M
$2.7B
+10.6%
Sixth Street Partners Management Company, L.P.
3.5%
21.6M
$2.7B
+100.0%
Vanguard Portfolio Management LLC
3.3%
19.9M
$2.5B
+2.0%
Geode Capital Management, LLC
2.6%
15.7M
$2.0B
+1.1%
Morgan Stanley
2.0%
12.2M
$1.5B
+6.6%
Jpmorgan Chase & CO
1.5%
9.5M
$1.2B
-10.1%
Franklin Resources INC
1.3%
7.8M
$972.8M
+12.2%
Recent insider transactions
Insider
Role
Date
Type
Shares
Value
Burgum Melissa A
officer: Chief Accounting Officer
2026-08-01
Buy
1K
—
Walsh John F
officer: CEO-The Americas
2026-08-14
Buy
24
—
Brudermueller Martin
director
2026-08-14
Buy
9
—
Travis Tracey Thomas
director
2026-08-14
Buy
15
—
Burgum Melissa A
officer: Chief Accounting Officer
2026-08-14
Buy
23
—
Nason Jennifer
director
2026-08-14
Buy
9
—
Uotani Masahiko
director
2026-08-14
Buy
9
—
Unruch Joel
officer: General Counsel/Corp Secretary
2026-08-14
Buy
88
—
What you'll find
Next Accenture plc (ACN) earnings date, the expected move and the estimates priced in
A clear Beat / Miss / In-line / Mixed verdict the moment Accenture plc reports
Revenue & EPS versus estimates, guidance and segment trends
Multi-lens price forecast — analyst, quant, technical and options views
Deep research: red flags, risk decoder and earnings-call sentiment
Technicals, options / implied volatility and unusual-activity signals
Hedge-fund and legendary-investor 13F holdings in Accenture plc (ACN)
Side-by-side peer and historical earnings comparison
Frequently asked questions
When is Accenture plc's next earnings date?
Accenture plc's (ACN) next scheduled earnings date is Oct 1, 2026. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Accenture plc (ACN) beat or miss earnings?
In Q3 FY2026, Accenture plc (ACN) posted mixed results — revenue of $18.7B versus the $18.8B estimate (-0.3% surprise) and EPS of $3.80 versus $3.70 expected (+2.7% surprise). Magnisto decodes every Accenture plc (ACN) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
How often does Accenture plc beat earnings estimates?
Over its last 8 reported quarters, Accenture plc (ACN) beat Wall Street EPS estimates 5 times, most recently a mixed result in Q4 FY2026. Magnisto tracks every Accenture plc (ACN) quarter's revenue and EPS versus consensus and grades each one Beat, Miss, In-line or Mixed at a unified ±2% threshold.
How much does Accenture plc stock move after earnings?
Over its last 8 quarterly reports, Accenture plc (ACN) moved an average of ±5.2% the day after earnings — ranging from -20.0% (Q4 FY2026) to +5.4% (Q2 FY2025). The stock rose after 3 of those 8 reports and fell after 4. Heading into its next report on Oct 1, 2026, options-implied volatility is pricing in a move of roughly ±15.7% (derived). Magnisto tracks the realized post-earnings move for every Accenture plc (ACN) quarter alongside the beat/miss verdict — past moves don't predict the next one.
Who are the largest shareholders of Accenture plc?
Institutions hold about 102.1% of Accenture plc's (ACN) shares outstanding as of the 2026-06-30 13F quarter. Its largest institutional holders include Blackrock, INC. (10.2%), Vanguard Capital Management LLC (6.5%), State Street Corp (5.0%). Magnisto lists Accenture plc's (ACN) top 13F holders with each stake size and its quarter-over-quarter change.
Are insiders buying or selling Accenture plc (ACN)?
In the most recent Form 4 filings Magnisto tracks, Accenture plc (ACN) insiders recorded 12 purchases and 0 sales — net buying. Insider transactions are one signal among many and are often routine (option exercises or scheduled 10b5-1 sales), so Magnisto shows the raw feed for you to judge.
What is the forecast for Accenture plc (ACN) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Accenture plc (ACN), anchored to the current $186.53 share price, so you can weigh the bull, base and bear cases for Accenture plc side by side.
Is Accenture plc (ACN) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Accenture plc fits your own thesis and risk profile. This is research, not investment advice.